Arsalan Arif: Content Curation vs. Content Marketing. Is It All Crap?

In this 3-minute audio snippet, Arsalan Arif, Publisher of ENDPOINTS, talks about the benefits versus the drawbacks of content curation versus content marketing for pharmaceutical marketers.

Anne C. Beal, M.D., MPH: Sanofi’s Definition of Patient Centricity

In this 2-minute audio snippet, Anne C. Beal, M.D., MPH, Sanofi, talks about patient centricity and Sanofi's commitment to engaging patients and improving outcomes.

Andrew Schorr: To Engage Patients Pharma Must Commit to the Long Haul

In this 3-minute audio snippet, Andrew Schorr, Founder and Host of PatientPower.info, notes that pharma agency accounts come and go, but patients are living with their conditions day in and day out. Pharma has to be careful, says Schorr, when approaching patients about how they view the commitment.

Ambre Morley: Vetting Celebrity Spokespersons to Ensure Return on Investment

In this 2-minute audio snippet, Ambre Morley, Associate Director, Product Communications, Novo Nordisk, talks about vetting Paula Deen as a paid celebrity spokesperson for the Novo Victoza diabetes drug franchise and the importance of measuring celebrity return on investment (ROI).

AMA Struggles to Reign in Consumer Drug Ads

You have to give kudos to the good doctors and policy makers of the American Medical Association for trying over the course of many to ban or in some way curtail direct-to-consumer drug ads by pharmaceutical companies. The latest effort focuses on drug price transparency in ads. Will it succeed where the other efforts have failed?

The Sorry State of Pharma Mobile Health Apps: Lack of Security, Continuity and Platform...

This articles summarizes some major points made in a presentation by Carolyn Gauntlett, Senior Innovation Consultant with IMS Health, titled 'How to Make Sure You're Getting the Most Out of Your mHealth App Development.'

FDA Publishes First Piece of Long-Awaited Social Media Guidance: Focus is on Accountability

A Public Affairs Specialist at FDA's Center for Drug Evaluation and Research (CDER) confirmed to several reporters that this guidance is actually PART of the long-awaited guidance that was promised after the November, 2009 public hearing and required by section 1121 of the Prescription Drug User Fee Act (PDUFA).

Leveraging Infographics and Search for Better Health Communications: Epilepsy Foundation/Lundbeck Case Study

One example of how pharma companies can use infographics to educate their stakeholders is the Epilepsy Foundation/Lundbeck nationwide initiative to bring information about managing seizures to people living with epilepsy and their families. This article discusses how Centric Infographics worked with the Foundation to create the infographic system at the center of this successful campaign.

Pharma Content Marketing Strategies: Insights from Industry Experts

This article includes insights on content marketing from pharma experts including Thibaud Guymard, Digital Marketing Manager at MSD France. Guymard has broad experience with pharma content marketing, including roles as co-creator of the Digital Health Think Tank and as an Advertising Manager at Saatchi & Saatchi Health. Guymard also assisted in developing the Pharma Content Marketing Webinar organized by Kakushin Webinars.

The Year 2013 in Images: Pharmaguy’s Favorites from Pharma Marketing Blog

Every year Pharmaguy reviews the images that appeared on Pharma Marketing Blog and picks his favorites. 2013 is no exception.